Chronic myeloid leukemia (CML) is characterized by the formation of Philadelphia chromosome and the generation of BCR-ABL fusion gene to encode the oncoprotein with deregulated tyrosine kinase activity. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.